0 Bewertungen

ID

42900

Beschreibung

Randomized Comparison Between Two Dose Levels of Daunorubicin and Between One Versus Two Cycles of Induction Therapy for Adult Patients With Acute Myeloid Leukemia <=60 Years. See: https://www.clinicaltrials.gov/ct2/show/NCT02140242 Copyright Holder: PD Dr. med. Christoph Röllig, MSc Source:PD Dr. med. Christoph Röllig, MSc Universitätsklinikum Dresden

Link

https://www.clinicaltrials.gov/ct2/show/NCT02140242

Stichworte

  1. 07.03.18 07.03.18 -
  2. 17.09.21 17.09.21 -
Rechteinhaber

Technische Universität Dresden,Dr. Röllig

Hochgeladen am

17. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    26496_Daunorubicin Acute Myeloid Leukemia NCT02140242

    Visit Randomization II

    Cytogenetics
    Beschreibung

    Cytogenetics

    Alias
    UMLS CUI-1
    C0010802
    Randomization number
    Beschreibung

    2DAUNO - xxx(local trial center number) - xxx(patient inclusion number) - xx(treatment arm part I)

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C2348585
    UMLS CUI [1,2]
    C0034656
    Cytogenetics analysis
    Beschreibung

    Cytogenetics analysis

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0752095
    Total Number of analyzed metaphases
    Beschreibung

    Number of analyzed metaphases

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1621812
    UMLS CUI [1,2]
    C0260877
    UMLS CUI [1,3]
    C0449788
    Karyotype
    Beschreibung

    Karyotype

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1261273
    UMLS CUI [1,2]
    C0678257
    If karyotype is not normal, which characteristics apply?
    Beschreibung

    Karyotype characteristics

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1261273
    UMLS CUI [1,2]
    C0008625
    Have you marked all karyotype characteristics?
    Beschreibung

    Complete

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0205197
    UMLS CUI [1,2]
    C1511726
    Chromosome aberrations
    Beschreibung

    Chromosome aberrations

    Alias
    UMLS CUI-1
    C0008625
    High risk aberrations
    Beschreibung

    High risk aberrations

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0008625
    UMLS CUI [1,2]
    C0684030
    Low risk aberrations
    Beschreibung

    Low risk aberrations

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0008625
    UMLS CUI [1,2]
    C3538919
    Other aberrations, please specify
    Beschreibung

    Other aberrations

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0008625
    UMLS CUI [1,2]
    C0205394
    Further entry
    Beschreibung

    Further entry

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C1705654
    UMLS CUI [1,2]
    C1517331
    Randomization II
    Beschreibung

    Randomization II

    Alias
    UMLS CUI-1
    C0034656
    Date of Randomization II
    Beschreibung

    Randomization Date

    Datentyp

    date

    Alias
    UMLS CUI [1,1]
    C0011008
    UMLS CUI [1,2]
    C0034656
    Percentage of blasts:
    Beschreibung

    (locally assessed in bone marrow at visit 7) xxx . x

    Datentyp

    float

    Maßeinheiten
    • %
    Alias
    UMLS CUI [1]
    C1982687
    %
    The patient is allocated to stratum
    Beschreibung

    Patient allocation, automatic entry

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1522541
    UMLS CUI [1,2]
    C1706778
    UMLS CUI [1,3]
    C0004374
    The patient is allocated to stratum
    Beschreibung

    Patient allocation

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C1522541
    UMLS CUI [1,2]
    C1706778
    UMLS CUI [1,3]
    C0175674
    By signing the “Rando II” form the local investigator has confirmed, that the patient can proceed to Randomization II.
    Beschreibung

    Study subject participation status confirmed

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C2348568
    UMLS CUI [1,2]
    C0750484
    The patient shall now be randomized
    Beschreibung

    Randomization

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0034656
    Result NON automatic randomization II
    Beschreibung

    Randomization result

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C0034656
    UMLS CUI [1,2]
    C1522541
    Randomization II Result
    Beschreibung

    Randomization II Result

    Alias
    UMLS CUI-1
    C0034656
    UMLS CUI-2
    C1274040
    Randomization number
    Beschreibung

    2DAUNO - xxx(local trial center number) - xxx(patient inclusion number) - xx(treatment arm part I) - x(treatment arm part II)

    Datentyp

    integer

    Alias
    UMLS CUI [1,1]
    C2348585
    UMLS CUI [1,2]
    C0034656
    Assigned Treatment Arm
    Beschreibung

    Treatment Arm

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1522541

    Ähnliche Modelle

    Visit Randomization II

    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Cytogenetics
    C0010802 (UMLS CUI-1)
    Randomization number
    Item
    Randomization number
    integer
    C2348585 (UMLS CUI [1,1])
    C0034656 (UMLS CUI [1,2])
    Item
    Cytogenetics analysis
    integer
    C0752095 (UMLS CUI [1])
    Code List
    Cytogenetics analysis
    CL Item
    Not done (1)
    CL Item
    Failed (e.g. technical problems, EDTA conditioned) (2)
    CL Item
    Failure (bad morphology, no proliferation) (3)
    CL Item
    Done (4)
    Number of analyzed metaphases
    Item
    Total Number of analyzed metaphases
    integer
    C1621812 (UMLS CUI [1,1])
    C0260877 (UMLS CUI [1,2])
    C0449788 (UMLS CUI [1,3])
    Item
    Karyotype
    integer
    C1261273 (UMLS CUI [1,1])
    C0678257 (UMLS CUI [1,2])
    Code List
    Karyotype
    CL Item
    Normal karyotype (1)
    CL Item
    Abnormal karyotype (2)
    Item
    If karyotype is not normal, which characteristics apply?
    integer
    C1261273 (UMLS CUI [1,1])
    C0008625 (UMLS CUI [1,2])
    Code List
    If karyotype is not normal, which characteristics apply?
    CL Item
    high risk aberrations (1)
    CL Item
    low risk aberrations (2)
    Complete
    Item
    Have you marked all karyotype characteristics?
    boolean
    C0205197 (UMLS CUI [1,1])
    C1511726 (UMLS CUI [1,2])
    Item Group
    Chromosome aberrations
    C0008625 (UMLS CUI-1)
    Item
    High risk aberrations
    integer
    C0008625 (UMLS CUI [1,1])
    C0684030 (UMLS CUI [1,2])
    Code List
    High risk aberrations
    CL Item
    -5 (1)
    C0439075 (UMLS CUI-1)
    (Comment:en)
    CL Item
    -7 (2)
    C3846158 (UMLS CUI-1)
    (Comment:en)
    CL Item
    abnl(17p) (3)
    C0796349 (UMLS CUI-1)
    (Comment:en)
    CL Item
    del(5q) (4)
    C1521461 (UMLS CUI-1)
    (Comment:en)
    CL Item
    inv(3)(q21q26.2) (5)
    C1515666 (UMLS CUI-1)
    (Comment:en)
    CL Item
    t(3;3)(q21;q26.2) (6)
    C1515764 (UMLS CUI-1)
    (Comment:en)
    CL Item
    t(6;9) (q23;q34) (7)
    C1515781 (UMLS CUI-1)
    (Comment:en)
    CL Item
    t(v;11)(v;q23) (8)
    C1515714 (UMLS CUI-1)
    (Comment:en)
    CL Item
    complex karyotype (≥ 3 aberrations) (9)
    C3273253 (UMLS CUI-1)
    (Comment:en)
    Item
    Low risk aberrations
    integer
    C0008625 (UMLS CUI [1,1])
    C3538919 (UMLS CUI [1,2])
    Code List
    Low risk aberrations
    CL Item
    inv(16) (1)
    C3897144 (UMLS CUI-1)
    (Comment:en)
    CL Item
    t(8;21) (2)
    C3897139 (UMLS CUI-1)
    (Comment:en)
    CL Item
    t(16;16) (3)
    C4287945 (UMLS CUI-1)
    (Comment:en)
    CL Item
    other aberrations (4)
    C0008625 (UMLS CUI-1)
    C0205394 (UMLS CUI-2)
    (Comment:en)
    Other aberrations
    Item
    Other aberrations, please specify
    text
    C0008625 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    Further entry
    Item
    Further entry
    boolean
    C1705654 (UMLS CUI [1,1])
    C1517331 (UMLS CUI [1,2])
    Item Group
    Randomization II
    C0034656 (UMLS CUI-1)
    Randomization Date
    Item
    Date of Randomization II
    date
    C0011008 (UMLS CUI [1,1])
    C0034656 (UMLS CUI [1,2])
    Bone marrow Blasts
    Item
    Percentage of blasts:
    float
    C1982687 (UMLS CUI [1])
    Item
    The patient is allocated to stratum
    integer
    C1522541 (UMLS CUI [1,1])
    C1706778 (UMLS CUI [1,2])
    C0004374 (UMLS CUI [1,3])
    Code List
    The patient is allocated to stratum
    CL Item
    non high risk (1)
    CL Item
    high risk (2)
    Item
    The patient is allocated to stratum
    integer
    C1522541 (UMLS CUI [1,1])
    C1706778 (UMLS CUI [1,2])
    C0175674 (UMLS CUI [1,3])
    Code List
    The patient is allocated to stratum
    CL Item
    non high risk (1)
    CL Item
    high risk (2)
    Study subject participation status confirmed
    Item
    By signing the “Rando II” form the local investigator has confirmed, that the patient can proceed to Randomization II.
    boolean
    C2348568 (UMLS CUI [1,1])
    C0750484 (UMLS CUI [1,2])
    Randomization
    Item
    The patient shall now be randomized
    boolean
    C0034656 (UMLS CUI [1])
    Randomization result
    Item
    Result NON automatic randomization II
    integer
    C0034656 (UMLS CUI [1,1])
    C1522541 (UMLS CUI [1,2])
    Item Group
    Randomization II Result
    C0034656 (UMLS CUI-1)
    C1274040 (UMLS CUI-2)
    Randomization number
    Item
    Randomization number
    integer
    C2348585 (UMLS CUI [1,1])
    C0034656 (UMLS CUI [1,2])
    Item
    Assigned Treatment Arm
    integer
    C1522541 (UMLS CUI [1])
    Code List
    Assigned Treatment Arm
    CL Item
    45 mg/m2 Daunorubicin day 3-5 during second induction (1)
    CL Item
    no second induction (2)
    CL Item
    60 mg/m2 Daunorubicin day 3-5 during second induction (3)

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video